XML 140 R120.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Note 19 - Stock-based Compensation - Options and SARS Outstanding (Details) shares in Thousands | Dec. 31, 2023 $ / shares shares
--- | ---
Number of SARs outstanding (in shares) | 440
SARs exercisable (in shares) | 336
Weighted average exercise price of SARs outstanding (in dollars per share) | $ / shares | $ 38.11
Stock Options and Stock Appreciation Rights SARs Expiring in 2024 [Member] |
Number of SARs outstanding (in shares) | 3
SARs exercisable (in shares) | 3
Weighted average exercise price of SARs outstanding (in dollars per share) | $ / shares | $ 19.44
Stock Options and Stock Appreciation Rights SARs Expiring in 2025 [Member] |
Number of SARs outstanding (in shares) | 39
SARs exercisable (in shares) | 39
Weighted average exercise price of SARs outstanding (in dollars per share) | $ / shares | $ 23.02
Stock Options and Stock Appreciation Rights SARs Expiring in 2026 [Member] |
Number of SARs outstanding (in shares) | 76
SARs exercisable (in shares) | 76
Weighted average exercise price of SARs outstanding (in dollars per share) | $ / shares | $ 25.76
Stock Appreciation Rights SARs Expiring in 2027 [Member] |
Number of SARs outstanding (in shares) | 40
SARs exercisable (in shares) | 40
Weighted average exercise price of SARs outstanding (in dollars per share) | $ / shares | $ 40
Stock Appreciation Rights SARs Expiring in 2028 [Member] |
Number of SARs outstanding (in shares) | 95
SARs exercisable (in shares) | 95
Weighted average exercise price of SARs outstanding (in dollars per share) | $ / shares | $ 37.84
Stock Appreciation Rights SARs Expiring in 2029 [Member] |
Number of SARs outstanding (in shares) | 47
SARs exercisable (in shares) | 37
Weighted average exercise price of SARs outstanding (in dollars per share) | $ / shares | $ 37.06
Stock Appreciation Rights SARs Expiring In 2030 [Member] |
Number of SARs outstanding (in shares) | 46
SARs exercisable (in shares) | 27
Weighted average exercise price of SARs outstanding (in dollars per share) | $ / shares | $ 37.3
Stock Appreciation Rights SARs Expiring In 2031 [Member] |
Number of SARs outstanding (in shares) | 31
SARs exercisable (in shares) | 12
Weighted average exercise price of SARs outstanding (in dollars per share) | $ / shares | $ 50.48
Stock Appreciation Rights SARs Expiring In 2032 [Member] |
Number of SARs outstanding (in shares) | 34
SARs exercisable (in shares) | 7
Weighted average exercise price of SARs outstanding (in dollars per share) | $ / shares | $ 55.45
Stock Appreciation Rights (SARS) Expiring In 2033 [Member] |
Number of SARs outstanding (in shares) | 29
SARs exercisable (in shares) | 0
Weighted average exercise price of SARs outstanding (in dollars per share) | $ / shares | $ 60.76

X
- Definition The number of shares reserved for issuance under stock option agreements and stock appreciation rights agreements awarded under the plan that validly exist and are outstanding as of the balance sheet date, including vested options. + References No definition available. + Details
Name: | sybt_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndSARsOutstandingNumber
Namespace Prefix: | sybt_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The weighted average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on stock options and stock appreciation rights awarded under the plans during the reporting period. + References No definition available. + Details
Name: | sybt_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndSARsOutstandingWeightedAverageExercisePrice
Namespace Prefix: | sybt_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of shares into which fully or partially vested stock options (or share units) and stock appreciation rights outstanding as of the balance sheet date can be currently converted under the plan. + References No definition available. + Details
Name: | sybt_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndSARsVestedAndExercisableNumber
Namespace Prefix: | sybt_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_AwardTypeAxis=sybt_StockOptionsAndStockAppreciationRightsSARsExpiringIn2024Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=sybt_StockOptionsAndStockAppreciationRightsSARsExpiringIn2025Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=sybt_StockOptionsAndStockAppreciationRightsSARsExpiringIn2026Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=sybt_StockAppreciationRightsSARsExpiringIn2027Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=sybt_StockAppreciationRightsSarsExpiringIn2028Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=sybt_StockAppreciationRightsSarsExpiringIn2029Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=sybt_StockAppreciationRightsSarsExpiringIn2030Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=sybt_StockAppreciationRightsSarsExpiringIn2031Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=sybt_StockAppreciationRightsSarsExpiringIn2032Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=sybt_StockAppreciationRightsSarsExpiringIn2033Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |